A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Natera, Inc. stock. As of the latest transaction made, Maverick Capital LTD holds 1,070,339 shares of NTRA stock, worth $136 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares
1,070,339
Previous 798,682 34.01%
Holding current value
$136 Million
Previous $73 Million 58.67%
% of portfolio
2.28%
Previous 1.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $23.2 Million - $30.6 Million
271,657 Added 34.01%
1,070,339 $116 Million
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $47.3 Million - $74.2 Million
798,682 New
798,682 $73 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.